FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3005609054> ?p ?o ?g. }

• W3005609054 abstract "Abstract Background Drug resistance is a major obstacle to treating cancers because it desensitizes cancer cells to chemotherapy. Recently, attention has been focused on changes in the tumor immune landscape after the acquisition of drug resistance. Programmed death-ligand-1 (PD-L1) is an immune suppressor that inhibits T cell-based immunity. Evidence has shown that acquired chemoresistance is associated with increased PD-L1 expression in cancer cells. However, the underlying mechanism is still largely unknown. Methods PD-L1 expression in three drug-resistant A549/CDDP, MCF7/ADR and HepG2/ADR cell lines was detected by qRT-PCR, western blotting and flow cytometry, and a T cell proliferation assay was performed to test its functional significance. Then, the potential roles of JNK/c-Jun, histone H3 acetylation, histone deacetylase 3 (HDAC3) and the E3 ligase COP1 in the PD-L1 increase were explored through ChIP assays and gain- and loss-of-function gene studies. Furthermore, murine xenograft tumor models were used to verify the role of JNK/c-Jun and HDAC3 in PD-L1 expression in A549/CDDP cells in vivo. Finally, the correlations of PD-L1, c-Jun and HDAC3 expression in clinical cisplatin-sensitive and cisplatin-resistant non-small cell lung cancer (NSCLC) tissues were analyzed by immunohistochemistry and Pearson’s correlation coefficient. Results PD-L1 expression was significantly increased in A549/CDDP, MCF7/ADR and HepG2/ADR cells and was attributed mainly to enhanced JNK/c-Jun signaling activation. Mechanistically, decreased COP1 increased c-Jun accumulation, which subsequently inhibited HDAC3 expression and thereby enhanced histone H3 acetylation of the PD-L1 promoter. Furthermore, PD-L1 expression could be inhibited by JNK/c-Jun inhibition or HDAC3 overexpression in vivo, which could largely reverse inhibited CD3 + T cell proliferation in vitro. PD-L1 expression was significantly increased in the cisplatin-resistant clinical NSCLC samples and positively correlated with c-Jun expression but negatively correlated with HDAC3 expression. Conclusions Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis was crucial for the PD-L1 increase in drug-resistant cancer cells. Our study reveals a novel regulatory network for the PD-L1 increase in drug-resistant cancer cells and that combined PD-L1-targeting strategies could improve T cell-based immunity in drug-resistant cancers." @default.
• W3005609054 created "2020-02-24" @default.
• W3005609054 creator A5020787482 @default.
• W3005609054 creator A5022526821 @default.
• W3005609054 creator A5025600821 @default.
• W3005609054 creator A5039626330 @default.
• W3005609054 creator A5049293174 @default.
• W3005609054 creator A5049531982 @default.
• W3005609054 creator A5056627707 @default.
• W3005609054 creator A5058814917 @default.
• W3005609054 creator A5073712215 @default.
• W3005609054 creator A5075819658 @default.
• W3005609054 creator A5080247777 @default.
• W3005609054 creator A5082694122 @default.
• W3005609054 creator A5085233592 @default.
• W3005609054 date "2020-02-05" @default.
• W3005609054 modified "2023-10-16" @default.
• W3005609054 title "Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1/c-Jun/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells" @default.
• W3005609054 cites W1206967436 @default.
• W3005609054 cites W158860515 @default.
• W3005609054 cites W1976903466 @default.
• W3005609054 cites W1992970966 @default.
• W3005609054 cites W2009781189 @default.
• W3005609054 cites W2038341052 @default.
• W3005609054 cites W2039147606 @default.
• W3005609054 cites W2053108443 @default.
• W3005609054 cites W2059409197 @default.
• W3005609054 cites W2072013301 @default.
• W3005609054 cites W2080294916 @default.
• W3005609054 cites W2089228335 @default.
• W3005609054 cites W2100413206 @default.
• W3005609054 cites W2102099949 @default.
• W3005609054 cites W2104347254 @default.
• W3005609054 cites W2115593774 @default.
• W3005609054 cites W2123959605 @default.
• W3005609054 cites W2138779676 @default.
• W3005609054 cites W2153162429 @default.
• W3005609054 cites W2265419075 @default.
• W3005609054 cites W2286393796 @default.
• W3005609054 cites W2292383635 @default.
• W3005609054 cites W2486455593 @default.
• W3005609054 cites W2497333816 @default.
• W3005609054 cites W2517381625 @default.
• W3005609054 cites W2558926434 @default.
• W3005609054 cites W2560367415 @default.
• W3005609054 cites W2572174216 @default.
• W3005609054 cites W2606367731 @default.
• W3005609054 cites W2626421530 @default.
• W3005609054 cites W2728491028 @default.
• W3005609054 cites W2738172640 @default.
• W3005609054 cites W2760106390 @default.
• W3005609054 cites W2766952249 @default.
• W3005609054 cites W2783117838 @default.
• W3005609054 cites W2784920809 @default.
• W3005609054 cites W2790574591 @default.
• W3005609054 cites W2889646458 @default.
• W3005609054 cites W2908117668 @default.
• W3005609054 cites W2913507075 @default.
• W3005609054 cites W2916858557 @default.
• W3005609054 cites W2920784460 @default.
• W3005609054 cites W2945219971 @default.
• W3005609054 cites W2950416140 @default.
• W3005609054 cites W2963629436 @default.
• W3005609054 cites W4376453126 @default.
• W3005609054 doi "https://doi.org/10.1186/s13046-020-1536-x" @default.
• W3005609054 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7003365" @default.
• W3005609054 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32024543" @default.
• W3005609054 hasPublicationYear "2020" @default.
• W3005609054 type Work @default.
• W3005609054 sameAs 3005609054 @default.
• W3005609054 citedByCount "38" @default.
• W3005609054 countsByYear W30056090542020 @default.
• W3005609054 countsByYear W30056090542021 @default.
• W3005609054 countsByYear W30056090542022 @default.
• W3005609054 countsByYear W30056090542023 @default.
• W3005609054 crossrefType "journal-article" @default.
• W3005609054 hasAuthorship W3005609054A5020787482 @default.
• W3005609054 hasAuthorship W3005609054A5022526821 @default.
• W3005609054 hasAuthorship W3005609054A5025600821 @default.
• W3005609054 hasAuthorship W3005609054A5039626330 @default.
• W3005609054 hasAuthorship W3005609054A5049293174 @default.
• W3005609054 hasAuthorship W3005609054A5049531982 @default.
• W3005609054 hasAuthorship W3005609054A5056627707 @default.
• W3005609054 hasAuthorship W3005609054A5058814917 @default.
• W3005609054 hasAuthorship W3005609054A5073712215 @default.
• W3005609054 hasAuthorship W3005609054A5075819658 @default.
• W3005609054 hasAuthorship W3005609054A5080247777 @default.
• W3005609054 hasAuthorship W3005609054A5082694122 @default.
• W3005609054 hasAuthorship W3005609054A5085233592 @default.
• W3005609054 hasBestOaLocation W30056090541 @default.
• W3005609054 hasConcept C104317684 @default.
• W3005609054 hasConcept C119157956 @default.
• W3005609054 hasConcept C121608353 @default.
• W3005609054 hasConcept C13721689 @default.
• W3005609054 hasConcept C153911025 @default.
• W3005609054 hasConcept C185592680 @default.
• W3005609054 hasConcept C190283241 @default.
• W3005609054 hasConcept C203014093 @default.
• W3005609054 hasConcept C2776694085 @default.
• W3005609054 hasConcept C2776745794 @default.

• next